The mTOR regulated RNA-binding protein LARP1 requires PABPC1 for guided mRNA interaction

Ewan M. Smith(Cancer Research UK), Martin Bushell(Cancer Research UK), Tobias Schmidt(Cancer Research UK), Anne E. Willis(University of Cambridge), Kelvin Cain(University of Cambridge), Carolyn Jones(University of Cambridge), Joseph A. Waldron(Cancer Research UK), Nour El Houda Benbahouche(Cancer Research UK), Rebekah Jukes‐Jones(University of Cambridge), Sarah L. Gillen(Cancer Research UK), Sarah P. Blagden(Churchill Hospital), Ania Wilczynska(Cancer Research UK), Katherine Louise Morris(University of Cambridge), Cameron Bell(Cancer Research UK), Hedda A. Meijer(University of Dundee), Bruno D. Fonseca(University of British Columbia), Mark Stoneley(University of Leeds)
Nucleic Acids Research
December 12, 2020
10.1093/nar/gkaa1189
Cited by 43

Related Papers

Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k
The complexity of miRNA-mediated repression
|Cell Death and Differentiation|2014|510
La-related Protein 1 (LARP1) Represses Terminal Oligopyrimidine (TOP) mRNA Translation Downstream of mTOR Complex 1 (mTORC1)
|Journal of Biological Chemistry|2015|279
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial
|The Lancet|2019|223
Performance status score: do patients and their oncologists agree?
|British Journal of Cancer|2003|222